Raysearch Laboratories Ab Stock Profit Margin
| RSLBF Stock | USD 26.74 2.74 11.42% |
RaySearch Laboratories AB fundamentals help investors to digest information that contributes to RaySearch Laboratories' financial success or failures. It also enables traders to predict the movement of RaySearch Pink Sheet. The fundamental analysis module provides a way to measure RaySearch Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RaySearch Laboratories pink sheet.
RaySearch |
RaySearch Laboratories AB Company Profit Margin Analysis
RaySearch Laboratories' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current RaySearch Laboratories Profit Margin | (0.01) % |
Most of RaySearch Laboratories' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RaySearch Laboratories AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, RaySearch Laboratories AB has a Profit Margin of -0.0082%. This is 99.93% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The profit margin for all United States stocks is 99.35% lower than that of the firm.
RaySearch Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RaySearch Laboratories' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RaySearch Laboratories could also be used in its relative valuation, which is a method of valuing RaySearch Laboratories by comparing valuation metrics of similar companies.RaySearch Laboratories is currently under evaluation in profit margin category among its peers.
RaySearch Fundamentals
| Return On Equity | -0.0097 | |||
| Return On Asset | -0.0023 | |||
| Profit Margin | (0.01) % | |||
| Current Valuation | 237.19 M | |||
| Shares Outstanding | 25.83 M | |||
| Shares Owned By Insiders | 4.00 % | |||
| Shares Owned By Institutions | 55.61 % | |||
| Price To Earning | 31.16 X | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 3.02 X | |||
| Revenue | 641.67 M | |||
| Gross Profit | 591.28 M | |||
| EBITDA | 197.36 M | |||
| Net Income | (47.31 M) | |||
| Cash And Equivalents | 5.96 M | |||
| Cash Per Share | 0.17 X | |||
| Total Debt | 13.74 M | |||
| Debt To Equity | 0.80 % | |||
| Current Ratio | 1.13 X | |||
| Book Value Per Share | 2.05 X | |||
| Cash Flow From Operations | 238.16 M | |||
| Number Of Employees | 373 | |||
| Beta | 1.45 | |||
| Market Capitalization | 192.68 M | |||
| Total Asset | 1.74 B | |||
| Working Capital | 223 M | |||
| Current Asset | 319 M | |||
| Current Liabilities | 96 M | |||
| Z Score | 8.4 | |||
| Net Asset | 1.74 B |
About RaySearch Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RaySearch Laboratories AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RaySearch Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RaySearch Laboratories AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in RaySearch Pink Sheet
RaySearch Laboratories financial ratios help investors to determine whether RaySearch Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RaySearch with respect to the benefits of owning RaySearch Laboratories security.